share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director RAPP EDWARD J

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director RAPP EDWARD J

艾伯維公司 | 4:持股變動聲明-董事 RAPP EDWARD J
美股SEC公告 ·  07/03 04:28

牛牛AI助理已提取核心訊息

Edward J. Rapp, a reporting person for AbbVie Inc. [ABBV], has been involved in a transaction with the company's stock. The action took place on June 30, 2024. However, the details regarding the nature of the transaction, including the number of shares traded, the transaction price, and the resulting ownership stake, have not been disclosed. Investors are advised to await further information for a complete understanding of the impact of this event on AbbVie's stock.
Edward J. Rapp, a reporting person for AbbVie Inc. [ABBV], has been involved in a transaction with the company's stock. The action took place on June 30, 2024. However, the details regarding the nature of the transaction, including the number of shares traded, the transaction price, and the resulting ownership stake, have not been disclosed. Investors are advised to await further information for a complete understanding of the impact of this event on AbbVie's stock.
艾伯維公司[ABBV]的申報人Edward J. Rapp參與了該公司的股票交易。此操作發生在2024年6月30日。然而,交易的性質、交易的股份數量、交易價格和最終所持有的股份尚未披露。建議投資者等待進一步信息,以充分了解此事件對艾伯維公司股票的影響。
艾伯維公司[ABBV]的申報人Edward J. Rapp參與了該公司的股票交易。此操作發生在2024年6月30日。然而,交易的性質、交易的股份數量、交易價格和最終所持有的股份尚未披露。建議投資者等待進一步信息,以充分了解此事件對艾伯維公司股票的影響。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。